Chinese General Practice ›› 2024, Vol. 27 ›› Issue (12): 1431-1437.DOI: 10.12114/j.issn.1007-9572.2023.0598
Special Issue: 心房颤动最新文章合辑; 心血管最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2023-09-14
Revised:
2023-11-27
Published:
2024-04-20
Online:
2024-01-23
Contact:
HAN Quanle
通讯作者:
韩全乐
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0598
项目 | 类别 | 测评方法 | CVH指标的量化评分(分) |
---|---|---|---|
健康行为 | 饮食状况 | 自述盐、高脂肪食物和茶的摄入量 | 1.盐①<6 g/d:100分;②6~12 g/d:50分;③>12 g/d:0分 2.高脂肪食物①<1次/周:100分;②1~3次/周:50分;③>3次/周:0分 3.饮茶①≥4次/周:100分;②1~3次/周:75分;③1~3次/月:50分;④<1次/月:25分;⑤从不:0分 |
体育活动 | 自我报告的每周体育活动次数 | ①>60 min:100分;②20~60 min:50分;③<20 min:0分 | |
尼古丁暴露 | 自我报告的香烟平均每日使用情况 | ①从不吸烟者:100分;②吸烟者戒烟≥1年:50分;③吸烟者<1支/d:25分;④吸烟者≥1支/d:0分 | |
睡眠时间 | 自我报告平均每晚睡眠时间 | ①7~<9 h:100分;②9~<10 h:90分;③6~<7 h:70分;④5~<6或≥10 h:40分;⑤4~<5 h:20分;⑥<4 h:0分 | |
健康因素 | BMI | 测量并计算:体质量(kg)/身高2(m2) | ①<23.0 kg/m2:100分;②23.0~24.9 kg/m2:75分;③25.0~29.9 kg/m2:50分;④30.0~34.9 kg/m2:25分;⑤≥35.0 kg/m2:0分 |
血脂水平 | 测量血浆总胆固醇和高密度脂蛋白胆固醇指标,并计算非高密度脂蛋白胆固醇 | ①<3.36 mmol/L:100分;②3.36~4.13 mmol/L:60分;③4.14~4.90 mmol/L:40分;④4.91~5.68 mmol/L:20分;⑤≥5.69 mmol/L:0分;如果是治疗后水平,减去20分 | |
血糖水平 | 测量空腹血糖(FBG) | ①无糖尿病史且FBG<5.6 mmol/L:100分;②无糖尿病史且FBG 5.6~6.9 mmol/L:60分;③糖尿病史且FBG<8.6 mmol/L:40分;④糖尿病史且FBG 8.6~10.1 mmol/L:30分;⑤糖尿病史且FBG 10.2~11.6 mmol/L:20分;⑥糖尿病史且FBG 11.7~13.2 mmol/L:10分;⑦糖尿病史且FBG≥13.3 mmol/L:0分 | |
血压水平 | 测量收缩压和舒张压 | ①<120/<80 mmHg:100分;②120~129/<80 mmHg:75分;③130~139/80~89 mmHg:50分;④140~159/90~99 mmHg:25分;⑤>160/≥100 mmHg:0分;如果是治疗后水平,减去20分 |
Table 1 Definition and quantitative scoring of cardiovascular health(Kailuan version of Life's Essential 8)
项目 | 类别 | 测评方法 | CVH指标的量化评分(分) |
---|---|---|---|
健康行为 | 饮食状况 | 自述盐、高脂肪食物和茶的摄入量 | 1.盐①<6 g/d:100分;②6~12 g/d:50分;③>12 g/d:0分 2.高脂肪食物①<1次/周:100分;②1~3次/周:50分;③>3次/周:0分 3.饮茶①≥4次/周:100分;②1~3次/周:75分;③1~3次/月:50分;④<1次/月:25分;⑤从不:0分 |
体育活动 | 自我报告的每周体育活动次数 | ①>60 min:100分;②20~60 min:50分;③<20 min:0分 | |
尼古丁暴露 | 自我报告的香烟平均每日使用情况 | ①从不吸烟者:100分;②吸烟者戒烟≥1年:50分;③吸烟者<1支/d:25分;④吸烟者≥1支/d:0分 | |
睡眠时间 | 自我报告平均每晚睡眠时间 | ①7~<9 h:100分;②9~<10 h:90分;③6~<7 h:70分;④5~<6或≥10 h:40分;⑤4~<5 h:20分;⑥<4 h:0分 | |
健康因素 | BMI | 测量并计算:体质量(kg)/身高2(m2) | ①<23.0 kg/m2:100分;②23.0~24.9 kg/m2:75分;③25.0~29.9 kg/m2:50分;④30.0~34.9 kg/m2:25分;⑤≥35.0 kg/m2:0分 |
血脂水平 | 测量血浆总胆固醇和高密度脂蛋白胆固醇指标,并计算非高密度脂蛋白胆固醇 | ①<3.36 mmol/L:100分;②3.36~4.13 mmol/L:60分;③4.14~4.90 mmol/L:40分;④4.91~5.68 mmol/L:20分;⑤≥5.69 mmol/L:0分;如果是治疗后水平,减去20分 | |
血糖水平 | 测量空腹血糖(FBG) | ①无糖尿病史且FBG<5.6 mmol/L:100分;②无糖尿病史且FBG 5.6~6.9 mmol/L:60分;③糖尿病史且FBG<8.6 mmol/L:40分;④糖尿病史且FBG 8.6~10.1 mmol/L:30分;⑤糖尿病史且FBG 10.2~11.6 mmol/L:20分;⑥糖尿病史且FBG 11.7~13.2 mmol/L:10分;⑦糖尿病史且FBG≥13.3 mmol/L:0分 | |
血压水平 | 测量收缩压和舒张压 | ①<120/<80 mmHg:100分;②120~129/<80 mmHg:75分;③130~139/80~89 mmHg:50分;④140~159/90~99 mmHg:25分;⑤>160/≥100 mmHg:0分;如果是治疗后水平,减去20分 |
变量 | 低CVH组(n=8 407) | 中CVH组(n=73 493) | 高CVH组(n=9 231) | F(χ2)值 | P值 |
---|---|---|---|---|---|
一般资料 | |||||
年龄( | 51.8±10.1 | 51.5±12.2 | 45.6±13.8 | 990.19 | <0.001 |
性别(男/女) | 8 032/375 | 59 762/13 731 | 4 593/4 638 | 6 470.62a | <0.001 |
受教育程度(高中及以上)[名(%)] | 1 383(16.47) | 13 680(18.63) | 3 284(35.60) | 1 544.83a | <0.001 |
家庭人均月收入(>1 000元)[名(%)] | 1 335(15.89) | 9 930(13.52) | 1 635(17.72) | 141.62a | <0.001 |
饮酒史[名(%)] | 5 669(67.46) | 26 554(36.15) | 1 811(19.62) | 4 541.15a | <0.001 |
LE8评分( | 44.12±5.08 | 66.05±7.85 | 83.80±2.89 | 65 625.70 | <0.001 |
饮食 | 34.77±17.10 | 38.55±14.57 | 42.93±15.87 | 661.41 | <0.001 |
体育活动 | 38.47±29.59 | 53.81±23.10 | 61.10±21.50 | 2 174.08 | <0.001 |
睡眠 | 70.30±29.51 | 88.53±20.84 | 96.06±11.54 | 3 648.32 | <0.001 |
烟草暴露 | 15.86±32.91b | 65.74±45.39 | 97.51±13.75 | 8 411.57 | <0.001 |
BMI | 51.62±21.18 | 66.88±23.79 | 92.06±15.11 | 7 378.81 | <0.001 |
Non-HDL-C | 49.17±27.95 | 73.90±27.74 | 93.64±15.53 | 4 862.02 | <0.001 |
FBG | 64.70±30.08 | 86.09±23.28 | 98.14±8.78 | 6 089.39 | <0.001 |
血压 | 28.05±31.00b | 55.46±33.22 | 89.00±15.55 | 8 291.86 | <0.001 |
Table 2 Comparison of general information and LE8 scores among the three groups of subjects
变量 | 低CVH组(n=8 407) | 中CVH组(n=73 493) | 高CVH组(n=9 231) | F(χ2)值 | P值 |
---|---|---|---|---|---|
一般资料 | |||||
年龄( | 51.8±10.1 | 51.5±12.2 | 45.6±13.8 | 990.19 | <0.001 |
性别(男/女) | 8 032/375 | 59 762/13 731 | 4 593/4 638 | 6 470.62a | <0.001 |
受教育程度(高中及以上)[名(%)] | 1 383(16.47) | 13 680(18.63) | 3 284(35.60) | 1 544.83a | <0.001 |
家庭人均月收入(>1 000元)[名(%)] | 1 335(15.89) | 9 930(13.52) | 1 635(17.72) | 141.62a | <0.001 |
饮酒史[名(%)] | 5 669(67.46) | 26 554(36.15) | 1 811(19.62) | 4 541.15a | <0.001 |
LE8评分( | 44.12±5.08 | 66.05±7.85 | 83.80±2.89 | 65 625.70 | <0.001 |
饮食 | 34.77±17.10 | 38.55±14.57 | 42.93±15.87 | 661.41 | <0.001 |
体育活动 | 38.47±29.59 | 53.81±23.10 | 61.10±21.50 | 2 174.08 | <0.001 |
睡眠 | 70.30±29.51 | 88.53±20.84 | 96.06±11.54 | 3 648.32 | <0.001 |
烟草暴露 | 15.86±32.91b | 65.74±45.39 | 97.51±13.75 | 8 411.57 | <0.001 |
BMI | 51.62±21.18 | 66.88±23.79 | 92.06±15.11 | 7 378.81 | <0.001 |
Non-HDL-C | 49.17±27.95 | 73.90±27.74 | 93.64±15.53 | 4 862.02 | <0.001 |
FBG | 64.70±30.08 | 86.09±23.28 | 98.14±8.78 | 6 089.39 | <0.001 |
血压 | 28.05±31.00b | 55.46±33.22 | 89.00±15.55 | 8 291.86 | <0.001 |
分组 | 人数 | 新发房颤[例(%)] | 随访时间(人年) | 发病密度(‰) | 累积发病率(%) |
---|---|---|---|---|---|
低CVH组 | 8 407 | 133(1.58) | 116 853 | 1.140 | 1.73 |
中CVH组 | 73 493 | 883(1.20) | 1 037 067 | 0.851 | 1.28 |
高CVH组 | 9 231 | 72(0.78) | 133 287 | 0.540 | 0.81 |
Table 3 New-onset AF in the three groups of subjects
分组 | 人数 | 新发房颤[例(%)] | 随访时间(人年) | 发病密度(‰) | 累积发病率(%) |
---|---|---|---|---|---|
低CVH组 | 8 407 | 133(1.58) | 116 853 | 1.140 | 1.73 |
中CVH组 | 73 493 | 883(1.20) | 1 037 067 | 0.851 | 1.28 |
高CVH组 | 9 231 | 72(0.78) | 133 287 | 0.540 | 0.81 |
变量 | β | SE | Wald χ2值 | P值 | HR值 | 95%CI |
---|---|---|---|---|---|---|
模型1 | ||||||
LE8评分分组(以低CVH组为参照) | ||||||
中CVH组 | -0.295 | 0.093 | 10.045 | 0.002 | 0.745 | 0.621~0.894 |
高CVH组 | -0.758 | 0.146 | 26.843 | <0.001 | 0.469 | 0.352~0.624 |
LE8评分 | -0.184 | 0.030 | 36.679 | <0.001 | 0.832 | 0.784~0.883 |
模型2 | ||||||
LE8评分分组(以低CVH组为参照) | ||||||
中CVH组 | -0.360 | 0.095 | 14.310 | <0.001 | 0.697 | 0.579~0.841 |
高CVH组 | -0.497 | 0.150 | 10.980 | 0.001 | 0.609 | 0.454~0.816 |
LE8评分 | -0.152 | 0.034 | 20.446 | <0.001 | 0.859 | 0.804~0.918 |
Table 4 Cox proportional hazards regression analysis of the impact of LE8 scoring groups on the risk of new-onset AF
变量 | β | SE | Wald χ2值 | P值 | HR值 | 95%CI |
---|---|---|---|---|---|---|
模型1 | ||||||
LE8评分分组(以低CVH组为参照) | ||||||
中CVH组 | -0.295 | 0.093 | 10.045 | 0.002 | 0.745 | 0.621~0.894 |
高CVH组 | -0.758 | 0.146 | 26.843 | <0.001 | 0.469 | 0.352~0.624 |
LE8评分 | -0.184 | 0.030 | 36.679 | <0.001 | 0.832 | 0.784~0.883 |
模型2 | ||||||
LE8评分分组(以低CVH组为参照) | ||||||
中CVH组 | -0.360 | 0.095 | 14.310 | <0.001 | 0.697 | 0.579~0.841 |
高CVH组 | -0.497 | 0.150 | 10.980 | 0.001 | 0.609 | 0.454~0.816 |
LE8评分 | -0.152 | 0.034 | 20.446 | <0.001 | 0.859 | 0.804~0.918 |
变量 | 模型1 | 模型2 | ||||
---|---|---|---|---|---|---|
P值 | HR值 | 95%CI | P值 | HR值 | 95%CI | |
饮食 | 0.610 | 0.985 | 0.927~1.045 | 0.468 | 0.978 | 0.921~1.039 |
体育活动 | <0.001 | 1.185 | 1.118~1.256 | 0.766 | 0.991 | 0.936~1.050 |
烟草暴露 | 0.049 | 1.063 | 1.000~1.129 | 0.226 | 1.047 | 0.972~1.127 |
睡眠 | <0.001 | 0.895 | 0.847~0.945 | 0.772 | 0.992 | 0.938~1.049 |
BMI | <0.001 | 0.777 | 0.732~0.825 | <0.001 | 0.762 | 0.717~0.809 |
Non-HDL-C | 0.147 | 1.046 | 0.984~1.111 | 0.079 | 1.055 | 0.994~1.121 |
FBG | 0.003 | 0.916 | 0.865~0.970 | 0.391 | 0.976 | 0.922~1.032 |
血压 | <0.001 | 0.683 | 0.645~0.724 | <0.001 | 0.824 | 0.776~0.876 |
Table 5 Cox proportional hazards regression analysis of the impact of LE8 single factor score on the risk of new-onset AF
变量 | 模型1 | 模型2 | ||||
---|---|---|---|---|---|---|
P值 | HR值 | 95%CI | P值 | HR值 | 95%CI | |
饮食 | 0.610 | 0.985 | 0.927~1.045 | 0.468 | 0.978 | 0.921~1.039 |
体育活动 | <0.001 | 1.185 | 1.118~1.256 | 0.766 | 0.991 | 0.936~1.050 |
烟草暴露 | 0.049 | 1.063 | 1.000~1.129 | 0.226 | 1.047 | 0.972~1.127 |
睡眠 | <0.001 | 0.895 | 0.847~0.945 | 0.772 | 0.992 | 0.938~1.049 |
BMI | <0.001 | 0.777 | 0.732~0.825 | <0.001 | 0.762 | 0.717~0.809 |
Non-HDL-C | 0.147 | 1.046 | 0.984~1.111 | 0.079 | 1.055 | 0.994~1.121 |
FBG | 0.003 | 0.916 | 0.865~0.970 | 0.391 | 0.976 | 0.922~1.032 |
血压 | <0.001 | 0.683 | 0.645~0.724 | <0.001 | 0.824 | 0.776~0.876 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
郝玉静,于洁,韩全乐,等. 心房颤动是否会增加新发心肌梗死发病风险?[J]. 中国全科医学,2022,25(17):2121-2126. DOI:10.12114/j.issn.1007-9572.2022.0056.
|
[6] |
|
[7] |
张爱丽,侯旗旗,韩全乐,等. 中国北方人群心房颤动与新发慢性肾脏病发病风险的相关性研究[J]. 中国全科医学,2023,26(36):4521-4526. DOI:10.12114/j.issn.1007-9572.2023.0006.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会,中国房颤中心联盟心房颤动防治专家工作委员会,等. 心房颤动:目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志,2022,26(1):15-88.
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,等.中国居民肥胖防治专家共识[J]. 中国预防医学杂志,2022,23(5):321-339. DOI:10.16506/j.1009-6639.2022.05.001.
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[1] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[2] | HE Ting, LI Jia, TAN Wenbin. Research Progress of Circulatory System Diseases and Secondary Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2101-2112. |
[3] | WANG Jie, SUN Guozhen, WANG Qin, BAO Zhipeng, GAO Min, WANG Lin. The Impact of Home-based Exercise Rehabilitation Compliance on the Recurrence of Atrial Fibrillation after Radiofrequency Ablation [J]. Chinese General Practice, 2025, 28(12): 1494-1499. |
[4] | YOU Zhanhong, SUN Guozhen, LU Jing, TANG Zhijie, WANG Jie, WANG Qin, WANG Lin. Latent Profile Analysis and Its Influencing Factors of Physical Activity in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(12): 1486-1493. |
[5] | BAO Zhipeng, LI Yunxia, WANG Jie, TANG Zhijie, YOU Zhanhong, HE Ying, SUN Guozhen. Research Progress of Perioperative Symptoms and Management Strategies in Patients Undergoing Catheter Ablation for Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(12): 1479-1485. |
[6] | BAI Lu, ZHANG Qiang, LIU Fangfang, SUN Caihong, FEI Sijie, XIN Caifeng. Correlation between Triglyceride Glucose Index and Atrial Fibrillation in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2025, 28(06): 720-728. |
[7] | CHENG Cheng, DU Weiwei, HE Fei, SHENG Jianlong, HUANG Zheng, WANG Xiaochen. The Value of Cardiac 3-Dimensional Computed Tomography in the Simplified Left Atrial Appendage Occlusion [J]. Chinese General Practice, 2024, 27(35): 4439-4445. |
[8] | LYU Yao, LIU Lidi, ZHOU Yiheng, JIA Yu, YANG Ziyu, CHEN Huadong, LIAO Xiaoyang, SHEN Can, LEI Yi. Interpretation of Neighborhoods and Cardiovaseular Health: a Seienifie Statement from the American HeartAssocialion [J]. Chinese General Practice, 2024, 27(35): 4358-4363. |
[9] | ZHOU Qibao, LUO Xiao, CHEN Ling, HE Huabin, YUAN Mingqing. A New Exploration for Evaluating the Stability of Warfarin Anticoagulation Therapy: Based on Modified SAMe-T-PDW2-LAD2 Score [J]. Chinese General Practice, 2024, 27(33): 4112-4118. |
[10] | ZHANG Qiang, TANG Min, GUANG Yajie, LIU Dan, ZHAO Xueyan, ZHAO Yuanyuan, ZHANG Lin, NUERBAHETI. Analysis of the Current Status of Atrial Fibrillation Epidemiological Survey in Shihezi Area of Xinjiang Corps [J]. Chinese General Practice, 2024, 27(33): 4162-4167. |
[11] | GAO Chenxi, CHEN Defang, CHEN Qingyong, SHEN Can, LIAO Xiaoyang. Updated Progress and Challenges in the Application of Wearable/Mobile Devices in the Management of Silent Atrial Fibrillation [J]. Chinese General Practice, 2024, 27(30): 3835-3840. |
[12] | WANG Xiaorui, ZHENG Ruoyao, SUN Fengzhi, ZHANG Shulong. Treatment Strategies for Atrial Fibrillation with Long Interval: Consensus and Controversy [J]. Chinese General Practice, 2024, 27(27): 3331-3335. |
[13] | TANG Zhijie, SUN Guozhen, GAO Min, WANG Jie, BAO Zhipeng, YANG Gang, WANG Lin, WANG Qin. Reasons for Refusal of Exercise Rehabilitation in Patients after Radiofrequency Ablation of Atrial Fibrillation in the Context Digital Medical Care: a Qualitative Research [J]. Chinese General Practice, 2024, 27(18): 2218-2224. |
[14] | YIN Qiuguo, QIN Xintong, ZHANG Yidan, JIANG Peng, GUO Ping, JIA Xingtai, JIAN Liguo. Correlation between Insulin Resistance Metabolic Score and Poor Prognosis in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2024, 27(18): 2179-2185. |
[15] | SHI Yushuang, WANG Huihua, LI Yan, LU Ping, SONG Wei, PAN Guijun. Analysis of the Effectiveness of Different Atrial Fibrillation Screening Methods in the Community-based Elderly Population [J]. Chinese General Practice, 2024, 27(11): 1316-1319. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||